Literature DB >> 8411360

Genetic determinants of dengue type 4 virus neurovirulence for mice.

H Kawano1, V Rostapshov, L Rosen, C J Lai.   

Abstract

Mouse-adapted dengue type 4 virus (DEN4) strain H241 is highly neurovirulent for mice, whereas its non-mouse-adapted parent is rarely neurovirulent. The genetic basis for the neurovirulence of the mouse-adapted mutant was studied by comparing intratypic chimeric viruses that contained the three structural protein genes from the parental virus or the neurovirulent mutant in the background sequence of nonneurovirulent DEN4 strain 814669. The chimera that contained the three structural protein genes from mouse neurovirulent DEN4 strain H241 proved to be highly neurovirulent in mice, whereas the chimera that contained the corresponding genes from its non-mouse-adapted parent was not neurovirulent. This finding indicates that most of the genetic loci for the neurovirulence of the DEN4 mutant lie within the structural protein genes. A comparison of the amino acid sequences of the parent and its mouse neurovirulent mutant proteins revealed that there were only five amino acid differences in the structural protein region, and three of these were located in the envelope (E) glycoprotein. Analysis of chimeras which contained one or two of the variant amino acids of the mutant E sequence substituting for the corresponding sequence of the parental virus identified two of these amino acid changes as important determinants of mouse neurovirulence. First, the single substitution of Ile for Thr-155 which ablated one of the two conserved glycosylation sites in parental E yielded a virus that was almost as neurovirulent as the mouse-adapted mutant. Thus, the loss of an E glycosylation site appears to play a role in DEN4 neurovirulence. Second, the substitution of Leu for Phe-401 also yielded a neurovirulent virus, but it was less neurovirulent than the glycosylation mutant. These findings indicate that at least two of the genetic loci responsible for DEN4 mouse neurovirulence map within the structural protein genes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8411360      PMCID: PMC238094     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Recent advances in our knowledge of dengue and sandfly fever.

Authors:  A B SABIN
Journal:  Am J Trop Med Hyg       Date:  1955-03       Impact factor: 2.345

2.  Noncytopathogenic variants of poliomyelitis viruses and resistance to superinfection in tissue culture.

Authors:  A B SABIN
Journal:  Science       Date:  1954-08-27       Impact factor: 47.728

3.  Nucleotide and complete amino acid sequences of Kunjin virus: definitive gene order and characteristics of the virus-specified proteins.

Authors:  G Coia; M D Parker; G Speight; M E Byrne; E G Westaway
Journal:  J Gen Virol       Date:  1988-01       Impact factor: 3.891

4.  Nucleotide sequence of dengue 2 RNA and comparison of the encoded proteins with those of other flaviviruses.

Authors:  Y S Hahn; R Galler; T Hunkapiller; J M Dalrymple; J H Strauss; E G Strauss
Journal:  Virology       Date:  1988-01       Impact factor: 3.616

5.  Variation of the nucleotide and encoded amino acid sequences of the envelope gene from eight dengue-2 viruses.

Authors:  J Blok; S Samuel; A J Gibbs; U T Vitarana
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

6.  Infectious RNA transcribed from stably cloned full-length cDNA of dengue type 4 virus.

Authors:  C J Lai; B T Zhao; H Hori; M Bray
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

7.  Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis.

Authors:  Y M Zhang; E P Hayes; T C McCarty; D R Dubois; P L Summers; K H Eckels; R M Chanock; C J Lai
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

8.  Heterogeneity in envelope protein sequence and N-linked glycosylation among yellow fever virus vaccine strains.

Authors:  P R Post; C N Santos; R Carvalho; A C Cruz; C M Rice; R Galler
Journal:  Virology       Date:  1992-05       Impact factor: 3.616

Review 9.  Pathogenesis of dengue: challenges to molecular biology.

Authors:  S B Halstead
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

10.  PRODUCTION OF IMMUNITY TO DENGUE WITH VIRUS MODIFIED BY PROPAGATION IN MICE.

Authors:  A B Sabin; R W Schlesinger
Journal:  Science       Date:  1945-06-22       Impact factor: 47.728

View more
  42 in total

Review 1.  Perspectives for the treatment of infections with Flaviviridae.

Authors:  P Leyssen; E De Clercq; J Neyts
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  Attenuation of Murray Valley encephalitis virus by site-directed mutagenesis of the hinge and putative receptor-binding regions of the envelope protein.

Authors:  R J Hurrelbrink; P C McMinn
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease.

Authors:  Vanessa V Sarathy; Mellodee White; Li Li; Summer R Gorder; Richard B Pyles; Gerald A Campbell; Gregg N Milligan; Nigel Bourne; Alan D T Barrett
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

4.  Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development.

Authors:  Claire Y-H Huang; Siritorn Butrapet; Kiyotaka R Tsuchiya; Natth Bhamarapravati; Duane J Gubler; Richard M Kinney
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

5.  Positive selection sites in the surface genes of dengue virus: phylogenetic analysis of the interserotypic branches of the four serotypes.

Authors:  Patsarin Rodpothong; Prasert Auewarakul
Journal:  Virus Genes       Date:  2012-01-06       Impact factor: 2.332

6.  Evolutionary relationships of endemic/epidemic and sylvatic dengue viruses.

Authors:  E Wang; H Ni; R Xu; A D Barrett; S J Watowich; D J Gubler; S C Weaver
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

7.  Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3.

Authors:  S Butrapet; C Y Huang; D J Pierro; N Bhamarapravati; D J Gubler; R M Kinney
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

8.  Enhanced neurovirulence of borna disease virus variants associated with nucleotide changes in the glycoprotein and L polymerase genes.

Authors:  Yoshii Nishino; Darwyn Kobasa; Steven A Rubin; Mikhail V Pletnikov; Kathryn M Carbone
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

9.  Mouse neuropathogenic poliovirus strains cause damage in the central nervous system distinct from poliomyelitis.

Authors:  M Gromeier; H H Lu; E Wimmer
Journal:  Microb Pathog       Date:  1995-04       Impact factor: 3.738

10.  Neuroadapted yellow fever virus 17D: genetic and biological characterization of a highly mouse-neurovirulent virus and its infectious molecular clone.

Authors:  T J Chambers; M Nickells
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.